- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
OncoPath Genomics
OncoPath Genomics is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Biomarkers
- Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
DNA & RNA
- DNA Extraction Extract DNA from an original source.
- Quantitative RT PCR Use quantitative reverse transcription polymerase chain reaction to measure absolute and relative mRNA abundance.
- RNA Extraction Isolate total RNA or mRNA from cells or tissues
In Vitro Assays
- Assay Development Construct or create new assays or modify existing ones.
Scientific Data Services
- Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
The company will penetrate the market in the design, patent and marketing of oncology diagnostic test kits for niche markets within the personalized medicine arena. The test service is based on the use of genomic testing and will allow oncologists to predict treatment response, thereby enabling individualized treatment decisions predicated on gene expression profiles. Such a technique would be especially useful for selecting cancer treatments, which often have low response rates and serious side effects. Initial efforts will be focused to develop a prognostic test to predict recurrence...
Show the full description
The company will penetrate the market in the design, patent and marketing of oncology diagnostic test kits for niche markets within the personalized medicine arena. The test service is based on the use of genomic testing and will allow oncologists to predict treatment response, thereby enabling individualized treatment decisions predicated on gene expression profiles. Such a technique would be especially useful for selecting cancer treatments, which often have low response rates and serious side effects. Initial efforts will be focused to develop a prognostic test to predict recurrence in lung cancer patients, and the company projects $4 million in sales by the end of third year. The company also recognizes the opportunities for developing personalized diagnostic tests/kits that are applicable to diverse treatment modalities such as surgery, radiotherapy and chemotherapy; and for many types of cancer within 5-10 years.
- Website
- www.oncopathgenomics.com
Work with OncoPath Genomics on Scientist.com
For prices, more details, or to contact OncoPath Genomics, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.